nach oben

Rheumatology International

Erschienen in:

29.08.2017 | Review on Health Services Research

Leveraging the electronic health record to improve quality and safety in rheumatology

verfasst von: Gabriela Schmajuk, Jinoos Yazdany

Erschienen in: Rheumatology International | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

During the last two decades, improving the quality and safety of healthcare has become a focus in rheumatology. Widespread use of electronic health records (EHRs) and the availability of digital data have the potential to drive quality improvement, improve patient outcomes, and prevent adverse events. In the coming years, developing and leveraging tools within the EHR will be the key to making the next big strides in improving the health of patients with rheumatoid arthritis and other rheumatic diseases, including building EHR infrastructure to capture patient outcomes and developing automated methods to retrieve information from free text of clinical notes.

Dragoi RG, Ndosi M, Sadlonova M et al (2013) Patient education, disease activity and physical function: can we be more targeted? A cross sectional study among people with rheumatoid arthritis, psoriatic arthritis and hand osteoarthritis. Arthrits Res Ther 15(5):R156CrossRef

Kjeken I, Dagfinrud H, Mowinckel P et al (2006) Rheumatology care: involvement in medical decisions, received information, satisfaction with care, and unmet health care needs in patients with rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum 55(3):394–401CrossRefPubMed

Nota I, Drossaert CH, Taal E et al (2014) Patient participation in decisions about disease modifying anti-rheumatic drugs: a cross-sectional survey. BMC Musculoskelet Disord 15:333CrossRefPubMedPubMedCentral

Bourgeois FT, Shannon MW, Valim C et al (2010) Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf 19(9):901–910CrossRefPubMedPubMedCentral

Russo E, Sittig DF, Murphy DR et al (2016) Challenges in patient safety improvement research in the era of electronic health records. Healthc (Amst) 4(4):285–290. doi:10.1016/j.hjdsi.2016.06.005 CrossRef

Smolen JS, Aletaha D, Bijlsma JWJ et al (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69(4):631–637CrossRefPubMedPubMedCentral

Institute of Medicine (2012) The learning health care system in America. National Academies Press, Washington, DC

Schoels M, Knevel R, Aletaha D et al (2010) Evidence for treating rheumatoid arthritis to target: results of a systematic literature search. Ann Rheum Dis 69:638–643CrossRefPubMedPubMedCentral

Grigor C, Capell H, Stirling A et al (2004) Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364:263–269CrossRefPubMed

10.

Verstappen SMM, Jacobs JWG, van der Veen MJ et al (2007) Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 66:1443–1449CrossRefPubMedPubMedCentral

11.

Allaart CF, Geokoop-Ruiterman YPM, de Vries-Bouwstra JK et al (2006) Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study. Clin Exp Rheumatol 24(6 Suppl 43):S-77–S-82

12.

Alemao E, Joo S, Kawabata H et al (2016) Effects of achieving target measures in rheumatoid arthritis on functional status, quality of life, and resource utilization: analysis of clinical practice data. Arthritis Care Res (Hoboken) 68(3):308–317CrossRef

13.

Curtis JR, Shan Y, Harrold L et al (2013) Patient perspectives on achieving treat-to-target goals: a critical examination of patient-reported outcomes. Arthritis Care Res (Hoboken) 65(10):1707–1712

14.

Lavallee DC, Chenok KE, Love RM et al (2016) Incorporating patient-reported outcomes into health care to engage patients and enhance care. Health Aff (Millwood) 35(4):575–582CrossRef

15.

National Quality Forum (2016) NQF-endorsed measures for musculoskeletal conditions. http://www.qualityforum.org/Publications/2015/01/NQF-Endorsed_Measures_for_Musculoskeletal_Conditions.aspx. Accessed 30 Jan 2017

16.

Yazdany J, Robbins M, Schmajuk G et al (2016) Development of the American College of Rheumatology’s rheumatoid arthritis electronic clinical quality measures. Arthritis Care Res 68(11):1579–1590CrossRef

17.

Yazdany J, Bansback N, Clowse MEB et al (2016) Practice-level variation in quality of care in the Acr’s Rheumatology Informatics System for Effectiveness (RISE) Registry [abstract]. Arthritis Rheumatol 68(suppl 10). http://acrabstracts.org/abstract/practice-level-variation-in-quality-of-care-in-the-acrs-rheumatology-informatics-system-for-effectiveness-rise-registry/. Accessed 30 Jan 2017

18.

Desai SP, Liu CC, Tory H et al (2014) Rheumatoid arthritis quality measures and radiographic progression. Semin Arthritis Rheum 44(1):9–13CrossRefPubMedPubMedCentral

19.

Navarro-Compan V, Smolen JS et al (2015) Quality indicators in rheumatoid arthritis: results from the METEOR database. Rheumatology (Oxford, England) 54(9):1630–1639CrossRef

20.

Sapir T, Rusie E, Greene L et al (2015) Influence of continuing medical education on rheumatologists’ performance on national quality measures for rheumatoid arthritis. Rheumatol Ther 2(2):141–151CrossRefPubMedPubMedCentral

21.

Yazdany J, Bansback N, Clowse M et al (2016) Rheumatology informatics system for effectiveness: a national informatics-enabled registry for quality improvement. Arthritis Care Res 68(12):1866–1873CrossRef

22.

Walsh SH (2004) The clinician’s perspective on electronic health records and how they can affect patient care. Br Med J 328:1184–1187CrossRef

23.

Newman E, Sharma T, Meadows A et al (2015) Rheumatoid arthritis quality measures—automated display of care gaps and capture of physician decision making at the clinic visit [abstract]. Arthritis Rheumatol 67(suppl 10). http://acrabstracts.org/abstract/rheumatoid-arthritis-quality-measures-automated-display-of-care-gaps-and-capture-of-physician-decision-making-at-the-clinic-visit/. Accessed 25 Jan 2017

24.

Powsner SM, Wyatt JC, Wright P (1998) Opportunities for and challenges of computerisation. Lancet 352:1617–1622CrossRefPubMed

25.

Brown T (2008) Design thinking. Harv Bus Rev 862008:84–92

26.

McCreary L (2010) Kaiser Permanente’s innovation on the front lines. Harv Bus Rev 7. https://hbr.org/2010/09/kaiser-permanentes-innovation-on-the-front-lines

27.

Carroll RJ, Thompson WK, Eyler AE et al (2012) Portability of an algorithm to identify rheumatoid arthritis in electronic health records. J Am Med Inform Assoc JAMIA 19(e1):e162–e169CrossRefPubMed

28.

Cannon GW, Mehortra S, South B et al (2016) A natural language processing system can capture rheumatoid arthritis disease activity measures in US veterans across multiple sites [abstract]. Arth Rheum 68(suppl 10). http://acrabstracts.org/abstract/a-natural-language-processing-system-can-capture-rheumatoid-arthritis-disease-activity-measures-in-us-veterans-across-multiple-sites/. Accessed 22 Jan 2017

29.

Liao KP, Cai T, Gainer V et al (2010) Electronic medical records for discovery research in rheumatoid arthritis. Arthritis Care Res (Hoboken) 62(8):1120–1127CrossRef

30.

Lin C, Karlson EW, Dligach D et al (2015) Automatic identification of methotrexate-induced liver toxicity in patients with rheumatoid arthritis from the electronic medical record. J Am Med Inform Assoc 22(e1):e151–e161CrossRefPubMed

31.

Hernandez Boussard T, Tamang S, Blayney D et al (2016) New paradigms for patient-centered outcomes research in electronic medical records: an example of detecting urinary incontinence following prostatectomy. EGEMS (Wash DC) 4(3):1231

32.

Tamang S, Patel MI, Blayney DW et al (2015) Detecting unplanned care from clinician notes in electronic health records. J Oncol Pract 11(3):e313–e319CrossRefPubMedPubMedCentral

33.

Tamang S, Podchiyska T, Gyuang E et al (2015) Electronic phenotyping for measuring quality of care. American Medical Informatics Association Joint Summit: Clinical Research Informatics [abstract]. https://knowledge.amia.org/amia-59309-cri2015-1.2002246/t-005-1.2003490/a-083-1.2003519/a-083-1.2003520/ap-083-1.2003521?qr=1

34.

Harpaz R, Callahan A, Tamang S et al (2014) Text mining for adverse drug events: the promise, challenges, and state of the art. Drug Saf 37(10):777–790CrossRefPubMedPubMedCentral

35.

Meystre SM, Savova GK, Kipper-Schuler KC, Hurdle JF (2008) Extracting information from textual documents in the electronic health record: a review of recent research. In: Yearbook of medical informatics, vol 35, pp 128–144

36.

Friedman C, Rindflesch TC, Corn M (2013) Natural language processing: state of the art and prospects for significant progress, a workshop sponsored by the National Library of Medicine. J Biomed Inform 46(5):765–773CrossRefPubMed

37.

Ford E, Carroll JA, Smith HE et al (2016) Extracting information from the text of electronic medical records to improve case detection: a systematic review. J Am Med Inform Assoc 23(5):1007–1015CrossRefPubMedPubMedCentral

38.

Perrillo RP, Martin P, Lok AS (2015) Preventing hepatitis B reactivation due to immunosuppressive drug treatments. JAMA 313(16):1617–1618CrossRefPubMed

39.

Yazdany J, Calabrese L (2010) Preventing hepatitis B reactivation in immunosuppressed patients: is it time to revisit the guidelines? Arthritis Care Res (Hoboken) 62(5):585–589CrossRef

40.

Keane J, Gershon S, Wise RP et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345(15):1098–1104CrossRefPubMed

41.

Carmona L, Hernandez-Garcia C, Vadillo C et al (2003) Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol 30(7):1436–1439PubMed

42.

Clowse ME, Magder L, Petri M (2005) Cyclophosphamide for lupus during pregnancy. Lupus 14(8):593–597CrossRefPubMed

43.

Jackson P, Paquette L, Watiker V et al (2009) Intrauterine exposure to mycophenolate mofetil and multiple congenital anomalies in a newborn: possible teratogenic effect. Am J Med Genet Part A 149A(6):1231–1236CrossRefPubMed

44.

Yazdany J, Trupin L, Kaiser R et al (2011) Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality? Arthritis Care Res (Hoboken) 63(3):358–365

45.

Schwarz EB, Longo LS, Zhao X et al (2010) Provision of potentially teratogenic medications to female veterans of childbearing age. Med Care 48(9):834–842CrossRefPubMed

46.

Hwang JP, Somerfield MR, Alston-Johnson DE et al (2015) Hepatitis B virus screening for patients with cancer before therapy: american society of clinical oncology provisional clinical opinion update. J Clin Oncol 33(19):2212–2220CrossRefPubMedPubMedCentral

47.

Weinbaum CM, Mast EE, Ward JW (2009) Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Hepatology 49(5 Suppl):S35–S44CrossRefPubMed

48.

Reddy KR, Beavers KL, Hammond SP et al (2015) American gastroenterological association institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology 148:215–219CrossRefPubMed

49.

Perrillo RP, Gish R, Falck-Ytter YT (2015) American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology 148(1):221–244CrossRefPubMed

50.

Huang YH, Hsiao LT, Hong YC et al (2013) Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B. J Clin Oncol 31:2765–2772CrossRefPubMed

51.

Buti M, Morillas R, Manzano ML et al (2014) Tenofovir for the prophylaxis of HBV reactivation in anti-HBc-positive patients with hematologic malignancies treated with rituximab: preliminary results of a randomized study (PREBLIN Study). J Hepatol 60(1):S421–S422CrossRef

52.

Kohler MJ, Amezaga M, Drozd J et al (2013) Use of a computerized order set to increase prescription of calcium and vitamin D supplementation in patients receiving glucocorticoids. J Gen Intern Med 28(6):825–829CrossRefPubMedPubMedCentral

53.

Chaudhry R, Schietel SM, North F et al (2013) Improving rates of herpes zoster vaccination with a clinical decision support system in a primary care practice. J Eval Clin Pract 19(2):263–266CrossRefPubMed

54.

van der Sijs H, Aarts J, Vulto A, Berg M (2006) Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc 13(2):138–147 (Epub 2005 Dec 15) CrossRefPubMedPubMedCentral

55.

Suter LG, Barber CE, Herrin J et al (2016) American College of Rheumatology White Paper on performance outcome measures in rheumatology. Arthritis Care Res (Hoboken) 68(10):1390–1401CrossRef

56.

Mannion R, Braithwaite J (2012) Unintended consequences of performance measurement in healthcare: 20 salutary lessons from the English National Health Service. Intern Med J 42(5):569–574CrossRefPubMed

57.

Ramsey CR, Matowe L, Grilli R et al (2003) Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behaviour change strategies. Int J Technol Assess Health Care 19(4):613–623CrossRef

58.

Harris AD, McGregor JC, Perencevich EN et al (2006) The use and interpretation of quasi-experimental studies in medical informatics. J Am Med Inform Assoc 13(1):16–23 (Epub 2005 Oct 12) CrossRefPubMedPubMedCentral

59.

Lewis RJ (2016) The pragmatic clinical trial in a learning health care system. Clin Trials 13(5):484–492CrossRefPubMed

60.

Mainous AG 3rd, Lambourne CA, Nietert PJ (2013) Impact of a clinical decision support system on antibiotic prescribing for acute respiratory infections in primary care: quasi-experimental trial. J Am Med Inform Assoc 20(2):317–324CrossRefPubMed

61.

Titsworth WL, Abram J, Guin P et al (2016) A prospective time-series quality improvement trial of a standardized analgesia protocol to reduce postoperative pain among neurosurgery patients. J Neurosurg 125(6):1523–1532CrossRefPubMed

62.

Green H, Paul M, Vidal L et al (2007) Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc 82(9):1052–1059CrossRefPubMed

63.

Jones RB, Tervaert JW, Hauser T et al (2010) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363(3):211–220CrossRefPubMed

64.

Singh JA, Furst DE, Bharat A et al (2012) 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 64(5):625–639CrossRef

65.

Bhatt DL, Scheiman J, Abraham NS et al (2008) ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol 103(11):2890CrossRefPubMed

66.

Saag KG, Teng GG, Patkar NM et al (2008) American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 59(6):762–784CrossRefPubMed

67.

Shea B, Swinden MV, Tanjong Ghogomu E et al (2013) Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev 41(6):1049–1060. doi:10.3899/jrheum.130738

68.

Marmor MF, Kellner U, Lai TY, American Academy of Ophthalmology et al (2016) Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology 2016(123):1386–1394CrossRef

Titel: Leveraging the electronic health record to improve quality and safety in rheumatology
verfasst von: Gabriela Schmajuk
Jinoos Yazdany
Publikationsdatum: 29.08.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Rheumatology International / Ausgabe 10/2017
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-017-3804-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Leveraging the electronic health record to improve quality and safety in rheumatology

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2017

Restless farewell

Reply to “Association of HLA-B27 and its subtypes with ankylosing spondylitis and clinical manifestations of ankylosing spondylitis in different HLA-B27 subtypes: comment on the article by Lin et al.”

A systematic review of the barriers affecting medication adherence in patients with rheumatic diseases

Clinical characteristics of methotrexate-associated lymphoproliferative disorders: relationship between absolute lymphocyte count recovery and spontaneous regression

Endothelin-1, α-Klotho, 25(OH) Vit D levels and severity of disease in scleroderma patients

Impaired quality of life after chikungunya virus infection: a 12-month follow-up study of its chronic inflammatory rheumatism in La Virginia, Risaralda, Colombia

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin